Infliximab (Remicade).
Reddy
P
P
Hartford Hospital, University of Connecticut, School of Pharmacy, Storrs, USA.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003424:Crohn Disease / Q000145:classification / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D000069285:Infliximab